Dr. Atul Deodhar presents data showing that secukinumab treated ankylosing spondylitis patients respond better when treated early. #EULAR2019 FRI0388 https://t.co/7swe9vpRdl

Dr. Christopher Ritchlin - New Phenotypic and Biomarket Predictors of Psoriatic Arthritis. Presentations from #EULAR2019 https://t.co/Z4YRuJbr51

Pulse methylpred does not improve survival or relapse but is associated with increased morbidity in AAV. Raashid Luqmani. #EULAR2019 https://t.co/NJPvGyCO2l

• Intravenous Pulse Methylprednisolone for Induction of Remission in Severe ANCA …

Rescreening for TB during bDMARDs might be a waste in a lot of countries, but in Romania it might be a different story (despite latent TB chemoprophylaxis). Infection risk depends on epidemiology #EULAR2019 FRI0076 @RheumNow https://t.co/2GuiW9oJkQ

Dr. Artie Kavanaugh - New Prednisone Revelations from #EULAR2019 https://t.co/ChAjGJpjF2

Nordic collaboration registry data: Etanercept vs Etanercept-biosimilar in SpA As expected, everything is SIMILAR #EULAR2019 https://t.co/BvYTs7bJi6

Receptor occupancy: sarilumab vs tocilizumab. Just going to leave this here without comment #EULAR2019 FRI0106 @RheumNow https://t.co/JFzWJw7phj

We must indicate the #Influenza vaccination to all the TNFi treated patients.. Dr. Giovanni Adami (Italy) #EULAR2019 https://t.co/5Cg6MKXhfc

@KarlGaffney1: extra-articular manifestations (EAMs) were present in 30% of people with #axialSpA in BSRBR-AS. EAMs did not appear to influence decision to prescribe 1st biologic but uveitis and IBD did influence which TNFi was chosen (i.e.monoclonal TNFi) #EULAR2019 https://t.co/3qSEPIvoxF

Quantitative magnetic resonance imaging T2 assessment of #muscle ➡️Could this be the future for detecting #myositis on #imaging? Matt Farrow is ready to present his work from @LeedsBRC 👉🏼FRI0637 #EULAR2019 #MRI https://t.co/HZoAaZG1hW

We are reporting via online streaming from the Congress! Watch the #EULARNews today on https://t.co/LojAOhMBcp at 08:30 and replay at 11:45, 13:30 and 16:45 (CEST) #EULAR2019 https://t.co/yPMULwRa9Z

• EULAR - European League against Rheumatism - YouTube

42% of early RA patients in Canadian CATCH cohort had prior inflamm joint palindromic-type symptoms (that ‘come and go’) and this subgroup had some interesting associations... #EULAR2019 FRI0065 @RheumNow @Janetbirdope https://t.co/tcjzObIfsB

Is there added value of antiCarP for RA dx? THU0139. Think of ACPA as citrullination vs CarP -carbamyllation Don't know if added value for dx but CarP equally + at nearly half in ACPA + &- so could it replace ACPA and use it with RF #EULAR2019 @RheumNow https://t.co/M7PfRysLel

Biosimilar interchangeability: different strokes for different folks... Gerd Burmester at #EULAR2019 @RheumNow https://t.co/JeZVzyvIZQ

1/4 flare upon discontinuation of Immunosuppressants in a retrospective Italian SLE cohort. In short term those who discontinued did not increase damage but this could be selection biased and also pts are generally promptly treated upon flare. #eular2019 @RheumNow